1. Home
  2. FRES vs MGRX Comparison

FRES vs MGRX Comparison

Compare FRES & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRES
  • MGRX
  • Stock Information
  • Founded
  • FRES 2010
  • MGRX 2021
  • Country
  • FRES United States
  • MGRX United States
  • Employees
  • FRES 75
  • MGRX N/A
  • Industry
  • FRES Medical Specialities
  • MGRX Computer Software: Prepackaged Software
  • Sector
  • FRES Health Care
  • MGRX Technology
  • Exchange
  • FRES Nasdaq
  • MGRX Nasdaq
  • Market Cap
  • FRES 6.4M
  • MGRX 9.3M
  • IPO Year
  • FRES 2020
  • MGRX 2023
  • Fundamental
  • Price
  • FRES $2.59
  • MGRX $0.42
  • Analyst Decision
  • FRES
  • MGRX
  • Analyst Count
  • FRES 0
  • MGRX 0
  • Target Price
  • FRES N/A
  • MGRX N/A
  • AVG Volume (30 Days)
  • FRES 10.6K
  • MGRX 1.6M
  • Earning Date
  • FRES 09-17-2024
  • MGRX 07-26-2024
  • Dividend Yield
  • FRES N/A
  • MGRX N/A
  • EPS Growth
  • FRES N/A
  • MGRX N/A
  • EPS
  • FRES N/A
  • MGRX N/A
  • Revenue
  • FRES $2,345,304.00
  • MGRX $844,866.00
  • Revenue This Year
  • FRES N/A
  • MGRX N/A
  • Revenue Next Year
  • FRES N/A
  • MGRX N/A
  • P/E Ratio
  • FRES N/A
  • MGRX N/A
  • Revenue Growth
  • FRES N/A
  • MGRX 670.43
  • 52 Week Low
  • FRES $2.50
  • MGRX $0.14
  • 52 Week High
  • FRES $41.50
  • MGRX $1.68
  • Technical
  • Relative Strength Index (RSI)
  • FRES 34.96
  • MGRX 57.25
  • Support Level
  • FRES $2.56
  • MGRX $0.32
  • Resistance Level
  • FRES $3.40
  • MGRX $0.47
  • Average True Range (ATR)
  • FRES 0.37
  • MGRX 0.04
  • MACD
  • FRES -0.03
  • MGRX 0.01
  • Stochastic Oscillator
  • FRES 7.50
  • MGRX 56.65

About FRES Fresh2 Group Limited

Fresh2 Group Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis, and recurrence.

About MGRX Mangoceuticals Inc.

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

Share on Social Networks: